A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia

Psychopharmacology

Volumn 202, Issue 1-3, 2009, Pages 237-258

  Sarter, Martin ^a   Martinez, Vicente ^a   Kozak, Rouba ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b PFIZER INC   (United States)

Author keywords

Amphetamine; Clozapine; Cognition; Haloperidol; Schizophrenia

Indexed keywords

ACETYLCHOLINE; AMPHETAMINE; CLOZAPINE; HALOPERIDOL;

ACUTE DISEASE; ANIMAL BEHAVIOR; ATTENTION; CHOLINERGIC SYSTEM; COGNITIVE DEFECT; DISEASE MODEL; LOW DRUG DOSE; NEUROPATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REMISSION; REVIEW; SCHIZOPHRENIA;

ANIMALS; ATTENTION; COGNITION; DISEASE MODELS, ANIMAL; HUMANS; MICE; RATS; SCHIZOPHRENIC PSYCHOLOGY; SYMPATHETIC NERVOUS SYSTEM;

EID: 59449095435     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-008-1216-6     Document Type: Review

References (202)

1. I Aasen V Kumari T Sharma 2005 Effects of rivastigmine on sustained attention in schizophrenia: an FMRI study J Clin Psychopharmacol 25 311 317
2. A Abi-Dargham R Gil J Krystal RM Baldwin JP Seibyl M Bowers CH van Dyck DS Charney RB Innis M Laruelle 1998 Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort Am J Psychiatry 155 761 767
3. J Addington D Addington E Maticka-Tyndale 1991 Cognitive functioning and positive and negative symptoms in schizophrenia Schizophr Res 5 123 134
4. N Amitai S Semenova A Markou 2007 Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats Psychopharmacology 193 521 537
5. NC Andreasen WT Carpenter Jr JM Kane RA Lasser SR Marder DR Weinberger 2005 Remission in schizophrenia: proposed criteria and rationale for consensus Am J Psychiatry 162 441 449
6. SM Antelman AJ Eichler CA Black D Kocan 1980 Interchangeability of stress and amphetamine in sensitization Science 207 329 331
7. HM Arnold JA Burk EM Hodgson M Sarter JP Bruno 2002 Differential cortical acetylcholine release in rats performing a sustained attention task versus behavioral control tasks that do not explicitly tax attention Neuroscience 114 451 460
8. E Bartlett A Hallin B Chapman B Angrist 1997 Selective sensitization to the psychosis-inducing effects of cocaine: a possible marker for addiction relapse vulnerability? Neuropsychopharmacology 16 77 82
9. AM Belcher SJ O'Dell JF Marshall 2006 A sensitizing regimen of methamphetamine causes impairments in a novelty preference task of object recognition Behav Brain Res 170 167 172
10. DS Bell 1965 Comparison of amphetamine psychosis and schizophrenia Br J Psychiatry 111 701 707
11. DS Bell 1973 The experimental reproduction of amphetamine psychosis Arch Gen Psychiatry 29 35 40
12. I Berman B Viegner A Merson E Allan D Pappas AI Green 1997 Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia Schizophr Res 25 1 10
13. JN Beuzen N Taylor K Wesnes A Wood 1999 A comparison of the effects of olanzapine, haloperidol and placebo on cognitive and psychomotor functions in healthy elderly volunteers J Psychopharmacol 13 152 158
14. P Birkett A Brindley P Norman G Harrison A Baddeley 2006 Control of attention in schizophrenia J Psychiatr Res 40 579 588
15. Bleuler E (1950) Dementia praecox or the group of schizophrenias. International Universities Press, New York
16. DL Braff 1993 Information processing and attention dysfunctions in schizophrenia Schizophr Bull 19 233 259
17. DL Braff GA Light 2004 Preattentional and attentional cognitive deficits as targets for treating schizophrenia Psychopharmacology 174 75 85
18. DL Braff DP Saccuzzo 1982 Effect of antipsychotic medication on speed of information processing in schizophrenic patients Am J Psychiatry 139 1127 1130
19. G Brebion X Amador MJ Smith D Malaspina Z Sharif JM Gorman 1999 Opposite links of positive and negative symptomatology with memory errors in schizophrenia Psychiatry Res 88 15 24
20. A Breier TP Su R Saunders RE Carson BS Kolachana A de Bartolomeis DR Weinberger N Weisenfeld AK Malhotra WC Eckelman D Pickar 1997 Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method Proc Natl Acad Sci U S A 94 2569 2574
21. PJ Bushnell WM Oshiro BK Padnos 1997 Detection of visual signals by rats: effects of chlordiazepoxide and cholinergic and adrenergic drugs on sustained attention Psychopharmacology 134 230 241
22. PJ Bushnell VA Benignus MW Case 2003 Signal detection behavior in humans and rats: a comparison with matched tasks Behav Processes 64 121 129
23. FP Bymaster DO Calligaro JF Falcone RD Marsh NA Moore NC Tye P Seeman DT Wong 1996 Radioreceptor binding profile of the atypical antipsychotic olanzapine Neuropsychopharmacology 14 87 96
24. G Cassens AK Inglis PS Appelbaum TG Gutheil 1990 Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients Schizophr Bull 16 477 499
25. SA Castner PS Goldman-Rakic 1999 Long-lasting psychotomimetic consequences of repeated low-dose amphetamine exposure in rhesus monkeys Neuropsychopharmacology 20 10 28
26. SA Castner PS Goldman-Rakic 2003 Amphetamine sensitization of hallucinatory-like behaviors is dependent on prefrontal cortex in nonhuman primates Biol Psychiatry 54 105 110
27. SA Castner PS Vosler PS Goldman-Rakic 2005 Amphetamine sensitization impairs cognition and reduces dopamine turnover in primate prefrontal cortex Biol Psychiatry 57 743 751
28. M Cheal 1984 Differential effects of haloperidol and clozapine on attention Psychopharmacology 84 268 273
29. RM Cohen WE Semple M Gross AC King TE Nordahl 1992 Metabolic brain pattern of sustained auditory discrimination Exp Brain Res 92 165 172
30. RM Cohen TE Nordahl WE Semple P Andreason D Pickar 1998 Abnormalities in the distributed network of sustained attention predict neuroleptic treatment response in schizophrenia Neuropsychopharmacology 19 36 47
31. JD Cohen DM Barch C Carter D Servan-Schreiber 1999 Context-processing deficits in schizophrenia: converging evidence from three theoretically motivated cognitive tasks J Abnorm Psychol 108 120 133
32. A Crider PR Solomon MA McMahon 1982 Disruption of selective attention in the rat following chronic d-amphetamine administration: relationship to schizophrenic attention disorder Biol Psychiatry 17 351 361
33. HS Crombag A Badiani TE Robinson 1996 Signalled versus unsignalled intravenous amphetamine: large differences in the acute psychomotor response and sensitization Brain Res 722 227 231
34. HS Crombag A Badiani S Maren TE Robinson 2000 The role of contextual versus discrete drug-associated cues in promoting the induction of psychomotor sensitization to intravenous amphetamine Behav Brain Res 116 1 22
35. HS Crombag A Badiani J Chan J Dell'Orco SP Dineen TE Robinson 2001 The ability of environmental context to facilitate psychomotor sensitization to amphetamine can be dissociated from its effect on acute drug responsiveness and on conditioned responding Neuropsychopharmacology 24 680 690
36. JM Crook E Tomaskovic-Crook DL Copolov B Dean 2000 Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation Biol Psychiatry 48 381 388
37. JM Crook E Tomaskovic-Crook DL Copolov B Dean 2001 Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment Am J Psychiatry 158 918 925
38. JW Dalley J McGaughy MT O'Connell RN Cardinal L Levita TW Robbins 2001 Distinct changes in cortical acetylcholine and noradrenaline efflux during contingent and noncontingent performance of a visual attentional task J Neurosci 21 4908 4914
39. JW Dalley DE Theobald D Berry JA Milstein K Laane BJ Everitt TW Robbins 2005 Cognitive sequelae of intravenous amphetamine self-administration in rats: evidence for selective effects on attentional performance Neuropsychopharmacology 30 525 537
40. V De Luca S Voineskos G Wong JL Kennedy 2006 Genetic interaction between alpha4 and beta2 subunits of high affinity nicotinic receptor: analysis in schizophrenia Exp Brain Res 174 292 296
41. B Dean M McLeod D Keriakous J McKenzie E Scarr 2002 Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia Mol Psychiatry 7 1083 1091
42. B Dean FP Bymaster E Scarr 2003 Muscarinic receptors in schizophrenia Curr Mol Med 3 419 426
43. Demeter E, Sarter M, Lustig C (2008) Rats and humans paying attention: cross-species task development for translational research. Neuropsychology, in press
44. C Deng XF Huang 2005 Decreased density of muscarinic receptors in the superior temporal gyrusin schizophrenia J Neurosci Res 81 883 890
45. S Dollfus M Petit 1995 Negative symptoms in schizophrenia: their evolution during an acute phase Schizophr Res 17 187 194
46. EH Ellinwood 1972
47. G Ellison MS Eison HS Huberman F Daniel 1978 Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration Science 201 276 278
48. SK Erickson SB Schwarzkopf D Palumbo J Badgley-Fleeman AM Smirnow GA Light 2005 Efficacy and tolerability of low-dose donepezil in schizophrenia Clin Neuropharmacol 28 179 184
49. BJ Everitt TW Robbins 1997 Central cholinergic systems and cognition Annu Rev Psychol 48 649 684
50. RE Featherstone S Kapur PJ Fletcher 2007 The amphetamine-induced sensitized state as a model of schizophrenia Prog Neuropsychopharmacol Biol Psychiatry 31 1556 1571
51. FM Filbey T Toulopoulou RG Morris C McDonald E Bramon M Walshe RM Murray 2008 Selective attention deficits reflect increased genetic vulnerability to schizophrenia Schizophr Res 101 169 175
52. AD Fisk MW Scerbo 1987 Automatic and control processing approach to interpreting vigilance performance: a review and reevaluation Hum Factors 29 653 660
53. PJ Fletcher CC Tenn Z Rizos V Lovic S Kapur 2005 Sensitization to amphetamine, but not PCP, impairs attentional set shifting: reversal by a D1 receptor agonist injected into the medial prefrontal cortex Psychopharmacology 183 190 200
54. PJ Fletcher CC Tenn J Sinyard Z Rizos S Kapur 2007 A sensitizing regimen of amphetamine impairs visual attention in the 5-choice serial reaction time test: reversal by a D1 receptor agonist injected into the medical prefrontal cortex Neuropsychopharmacology 32 1122 1132
55. SB Floresco MA Geyer LH Gold AA Grace 2005 Developing predictive animal models and establishing a preclinical trials network for assessing treatment effects on cognition in schizophrenia Schizophr Bull 31 888 894
56. JI Friedman 2004 Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists Psychopharmacology 174 45 53
57. JI Friedman DN Adler E Howanitz PD Harvey G Brenner H Temporini L White M Parrella KL Davis 2002 A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia Biol Psychiatry 51 349 357
58. RL Fuller SJ Luck EL Braun BM Robinson RP McMahon JM Gold 2006 Impaired control of visual attention in schizophrenia J Abnorm Psychol 115 266 275
59. CD Gilbert M Sigman 2007 Brain states: top-down influences in sensory processing Neuron 54 677 696
60. TM Gill M Sarter B Givens 2000 Sustained visual attention performance-associated prefrontal neuronal activity: evidence for cholinergic modulation J Neurosci 20 4745 4757
61. JM Gold RL Fuller BM Robinson EL Braun SJ Luck 2007 Impaired top-down control of visual search in schizophrenia Schizophr Res 94 148 155
62. TE Goldberg KJ Patterson Y Taqqu K Wilder 1998 Capacity limitations in short-term memory in schizophrenia: tests of competing hypotheses Psychol Med 28 665 673
63. G Goldstein WJ Shemansky 1995 Influences on cognitive heterogeneity in schizophrenia Schizophr Res 18 59 69
64. M Gorissen JC Sanz B Schmand 2005 Effort and cognition in schizophrenia patients Schizophr Res 78 199 208
65. Y Goto AA Grace 2005 Dopamine-dependent interactions between limbic and prefrontal cortical plasticity in the nucleus accumbens: disruption by cocaine sensitization Neuron 47 255 266
66. MF Green 1996 What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153 321 330
67. MF Green SR Marder SM Glynn SR McGurk WC Wirshing DA Wirshing RP Liberman J Mintz 2002 The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone Biol Psychiatry 51 972 978
68. G Grigoryan H Hodges S Mitchell JD Sinden JA Gray 1996 6-OHDA lesions of the nucleus accumbens accentuate memory deficits in animals with lesions to the forebrain cholinergic projection system: effects of nicotine administration on learning and memory in the water maze Neurobiol Learn Mem 65 135 153
69. C Grillon E Courchesne R Ameli MA Geyer DL Braff 1990 Increased distractibility in schizophrenic patients. Electrophysiologic and behavioral evidence Arch Gen Psychiatry 47 171 179
70. C Grillon R Ameli E Courchesne DL Braff 1991 Effects of task relevance and attention on P3 in schizophrenic patients Schizophr Res 4 11 21
71. JH Gruzelier NV Hammond 1978 The effect of chlorpromazine upon psychophysiological, endocrine and information processing measures in schizophrenia J Psychiatr Res 14 167 182
72. RE Gur BI Turetsky J Loughead W Snyder C Kohler M Elliott R Pratiwadi JD Ragland WB Bilker SJ Siegel SJ Kanes SE Arnold RC Gur 2007 Visual attention circuitry in schizophrenia investigated with oddball event-related functional magnetic resonance imaging Am J Psychiatry 164 442 449
73. JJ Hagan DN Jones 2005 Predicting drug efficacy for cognitive deficits in schizophrenia Schizophr Bull 31 830 853
74. ME Hasselmo J McGaughy 2004 High acetylcholine levels set circuit dynamics for attention and encoding and low acetylcholine levels set dynamics for consolidation Progr Brain Res 145 201 231
75. L Heimer 2000 Basal forebrain in the context of schizophrenia Brain Res Rev 31 205 235
76. AM Himmelheber M Sarter JP Bruno 1997 Operant performance and cortical acetylcholine release: role of response rate, reward density, and non-contingent stimuli Cogn Brain Res 6 23 36
77. AM Himmelheber M Sarter JP Bruno 2000 Increases in cortical acetylcholine release during sustained attention performance in rats Cogn Brain Res 9 313 325
78. H Homayoun B Moghaddam 2006 Progression of cellular adaptations in medial prefrontal and orbitofrontal cortex in response to repeated amphetamine J Neurosci 26 8025 8039
79. KM Hughes L Popi DL Wolgin 1998 Experiential constraints on the development of tolerance to amphetamine hypophagia following sensitization of stereotypy: instrumental contingencies regulate the expression of sensitization Psychopharmacology 140 445 449
80. TM Hyde JM Crook 2001 Cholinergic systems and schizophrenia: primary pathology or epiphenomena? J Chem Neuroanat 22 53 63
81. J Ichikawa J Dai IA O'Laughlin WL Fowler HY Meltzer 2002 Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum Neuropsychopharmacology 26 325 339
82. DS Janowsky C Risch 1979 Amphetamine psychosis and psychotic symptoms Psychopharmacology 65 73 77
83. S Jazbec C Pantelis T Robbins T Weickert DR Weinberger TE Goldberg 2007 Intra-dimensional/extra-dimensional set-shifting performance in schizophrenia: impact of distractors Schizophr Res 89 339 349
84. S Kapur 2003 Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia Am J Psychiatry 160 13 23
85. SR Kay 1990 Significance of the positive-negative distinction in schizophrenia Schizophr Bull 16 635 652
86. RS Keefe LJ Seidman BK Christensen RM Hamer T Sharma MM Sitskoorn RR Lewine DA Yurgelun-Todd RC Gur M Tohen GD Tollefson TM Sanger JA Lieberman 2004 Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol Am J Psychiatry 161 985 995
87. RS Keefe RM Bilder PD Harvey SM Davis BW Palmer JM Gold HY Meltzer MF Green D Miller del JM Canive LW Adler TC Manschreck M Swartz R Rosenheck DO Perkins TM Walker TS Stroup JP McEvoy JA Lieberman 2006 Baseline neurocognitive deficits in the CATIE schizophrenia trial Neuropsychopharmacology 31 2033 2046
88. RS Keefe AK Malhotra HY Meltzer JM Kane RW Buchanan A Murthy M Sovel L Chunming R Goldman 2008 Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial Neuropsychopharmacology 33 1217 1228
89. DJ King 1990 The effect of neuroleptics on cognitive and psychomotor function Br J Psychiatry 157 799 811
90. HS Koelega JA Brinkman B Zwep MN Verbaten 1990 Dynamic vs static stimuli in their effect on visual vigilance performance Percept Mot Skills 70 823 831
91. L Kokkinidis H Anisman 1981 Amphetamine psychosis and schizophrenia: a dual model Neurosci Biobehav Rev 5 449 461
92. RL Kondrad JA Burk 2004 Transient disruption of attentional performance following escalating amphetamine administration in rats Psychopharmacology 175 436 442
93. R Kozak JP Bruno M Sarter 2006 Augmented prefrontal acetylcholine release during challenged attentional performance Cereb Cortex 16 9 17
94. R Kozak V Martinez D Young H Brown JP Bruno M Sarter 2007 Toward a neuro-cognitive animal model of the cognitive symptoms of schizophrenia: disruption of cortical cholinergic neurotransmission following repeated amphetamine exposure in attentional task-performing, but not non-performing, rats Neuropsychopharmacology 32 2074 2086
95. Kraepelin E (1907) Clinical psychiatry. Scholars' facsimiles & reprints (1981 edition), Delmar
96. Kraepelin E (1919) Dementia praecox and paraphrenia (Facsimile 1971 Edition). Robert E. Krieger, Huntington
97. MK Lai OF Lai J Keene MM Esiri PT Francis T Hope CP Chen 2001 Psychosis of Alzheimer's disease is associated with elevated muscarinic M2 binding in the cortex Neurology 57 805 811
98. J Lameh ES Burstein E Taylor DM Weiner KE Vanover DW Bonhaus 2007 Pharmacology of N-desmethylclozapine Pharmacol Ther 115 223 231
99. M Laruelle 2000 The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies Brain Res Rev 31 371 384
100. M Laruelle A Abi-Dargham 1999 Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies J Psychopharmacol 13 358 371
101. M Laruelle A Abi-Dargham R Gil L Kegeles R Innis 1999 Increased dopamine transmission in schizophrenia: relationship to illness phases Biol Psychiatry 46 56 72
102. PA LeDuc G Mittleman 1995 Schizophrenia and psychostimulant abuse: a review and re-analysis of clinical evidence Psychopharmacology 121 407 427
103. Z Li M Huang J Ichikawa J Dai HY Meltzer 2005 N-desmethylclozapine, a major metabolite of clozapine, increases cortical acetylcholine and dopamine release in vivo via stimulation of M1 muscarinic receptors Neuropsychopharmacology 30 1986 1995
104. JA Lieberman BJ Kinon AD Loebel 1990 Dopaminergic mechanisms in idiopathic and drug-induced psychoses Schizophr Bull 16 97 110
105. JA Lieberman BB Sheitman BJ Kinon 1997 Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity Neuropsychopharmacology 17 205 229
106. F Lieh-Mak PW Lee 1997 Cognitive deficit measures in schizophrenia: factor structure and clinical correlates Am J Psychiatry 154 39 46
107. SJ Luck JM Gold 2008 The construct of attention in schizophrenia Biol Psychiatry 64 34 39
108. GW MacEwan TS Ehmann I Khanbhai C Wrixon 2001 Donepezil in schizophrenia-is it helpful? An experimental design case study Acta Psychiatr Scand 104 469 472
109. D Mancama MJ Arranz S Landau R Kerwin 2003 Reduced expression of the muscarinic 1 receptor cortical subtype in schizophrenia Am J Med Genet B Neuropsychiatr Genet 119 2 6
110. CM Mar DA Smith M Sarter 1996 Behavioural vigilance in schizophrenia. Evidence for hyperattentional processing Br J Psychiatry 169 781 789
111. SR Marder RF Asarnow T Van Putten 1984 Information processing and neuroleptic response in acute and stabilized schizophrenic patients Psychiatry Res 13 41 49
112. V Martinez M Sarter 2004 Lateralized attentional functions of cortical cholinergic inputs Behav Neurosci 118 984 991
113. Martinez V, Sarter M (2008) Detection of the moderately beneficial cognitive effects of low-dose treatment with haloperidol or clozapine in an animal model of the attentional impairments of schizophrenia. Neuropsychopharmacology, in press
114. V Martinez V Parikh M Sarter 2005 Sensitized attentional performance and Fos-immunoreactive cholinergic neurons in the basal forebrain of amphetamine-pretreated rats Biol Psychiatry 57 1138 1146
115. JH Maunsell 2004 Neuronal representations of cognitive state: reward or attention? Trends Cogn Sci 8 261 265
116. J McGaughy M Sarter 1995 Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands Psychopharmacology 117 340 357
117. J McGaughy T Kaiser M Sarter 1996 Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density Behav Neurosci 110 247 265
118. J McGaughy BJ Everitt TW Robbins M Sarter 2000 The role of cortical cholinergic afferent projections in cognition: impact of new selective immunotoxins Behav Brain Res 115 251 263
119. A McGhie J Chapman 1961 Disorders of attention and perception in early schizophrenia Brit J Med Psychol 34 103 117
120. TM McKenna JH Ashe NM Weinberger 1989 Cholinergic modulation of frequency receptive fields in auditory cortex: I. Frequency-specific effects of muscarinic agonists Synapse 4 30 43
121. GA Miller 2003 The cognitive revolution: a historical perspective Trends Cogn Sci 7 141 144
122. MJ Minzenberg JH Poole C Benton S Vinogradov 2004 Association of anticholinergic load with impairment of complex attention and memory in schizophrenia Am J Psychiatry 161 116 124
123. AL Mishara TE Goldberg 2004 A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book Biol Psychiatry 55 1013 1022
124. H Moore AR West AA Grace 1999 The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia Biol Psychiatry 46 40 55
125. Morel BA (1860) Traité des maladies mentales. Masson, Paris
126. ME Morgan JW Gibb 1980 Short-term and long-term effects of methamphetamine on biogenic amine metabolism in extra-striatal dopaminergic nuclei Neuropharmacology 19 989 995
127. S Mori G Tanaka Y Ayaka S Michitsuji H Niwa M Uemura Y Ohta 1996 Preattentive and focal attentional processes in schizophrenia: a visual search study Schizophr Res 22 69 76
128. AM Mortimer CE Lund PJ McKenna 1990 The positive:negative dichotomy in schizophrenia Br J Psychiatry 157 41 49
129. GN Neigh HM Arnold M Sarter JP Bruno 2001 Dissociations between the effects of intra-accumbens administration of amphetamine and exposure to a novel environment on accumbens dopamine and cortical acetylcholine release Brain Res 894 354 358
130. GN Neigh HM Arnold RL Rabenstein M Sarter JP Bruno 2004 Neuronal activity in the nucleus accumbens is necessary for performance-related increases in cortical acetylcholine release Neuroscience 123 635 645
131. CL Nelson M Sarter JP Bruno 2005 Prefrontal cortical modulation of acetylcholine release in posterior parietal cortex Neuroscience 132 347 359
132. KA Newell K Zavitsanou SK Jew XF Huang 2007 Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia Prog Neuropsychopharmacol Biol Psychiatry 31 225 233
133. AC Nobre GN Sebestyen DR Gitelman CD Frith MM Mesulam 2002 Filtering of distractors during visual search studied by positron emission tomography Neuroimage 16 968 976
134. KH Nuechterlein ME Dawson 1984 Information processing and attentional functioning in the developmental course of schizophrenic disorders Schizophr Bull 10 160 203
135. KH Nuechterlein ME Dawson MF Green 1994 Information-processing abnormalities as neuropsychological vulnerability indicators for schizophrenia Acta Psychiatr Scand (Suppl) 384 71 79
136. PM O'Flanagan RB Taylor 1950 A case of recurrent psychosis associated with amphetamine addiction J Ment Sci 96 1033 1036
137. ML O'Neil R Kuczenski DS Segal AK Cho G Lacan WP Melega 2006 Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge Synapse 60 465 473
138. E Oldford MA Castro-Alamancos 2003 Input-specific effects of acetylcholine on sensory and intracortical evoked responses in the "barrel cortex" in vivo Neuroscience 117 769 778
139. TF Oltmanns 1978 Selective attention in schizophrenic and manic psychoses: the effect of distraction on information processing J Abnorm Psychol 87 212 225
140. TF Oltmanns JM Neale 1975 Schizophrenic performance when distractors are present: attentional deficit or differential task difficulty? J Abnorm Psychol 84 205 209
141. TF Oltmanns J Ohayon JM Neale 1978 The effect of anti-psychotic medication and diagnostic criteria on distractibility in schizophrenia J Psychiatr Res 14 81 91
142. MA Parada L Hernandez M Puig de Parada P Rada E Murzi 1997 Selective action of acute systemic clozapine on acetylcholine release in the rat prefrontal cortex by reference to the nucleus accumbens and striatum J Pharmacol Exp Ther 281 582 588
143. R Parasuraman M Mouloua 1987 Interaction of signal discriminability and task type in vigilance decrement Percept Psychophys 41 17 22
144. JV Pardo PT Fox ME Raichle 1991 Localization of a human system for sustained attention by positron emission tomography Nature 349 61 64
145. V Parikh R Kozak V Martinez M Sarter 2007 Prefrontal acetylcholine release controls cue detection on multiple timescales Neuron 56 141 154
146. V Parikh K Man MW Decker M Sarter 2008 Glutamatergic contributions to nAChR agonist-evoked cholinergic transients in the prefrontal cortex J Neurosci 28 3769 3780
147. F Passetti JW Dalley MT O'Connell BJ Everitt TW Robbins 2000 Increased acetylcholine release in the rat medial prefrontal cortex during performance of a visual attentional task Eur J Neurosci 12 3051 3058
148. PE Paulson TE Robinson 1995 Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats Synapse 19 56 65
149. PE Paulson DM Camp TE Robinson 1991 Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats Psychopharmacology 103 480 492
150. P Powchik M Davidson V Haroutunian SM Gabriel DP Purohit DP Perl PD Harvey KL Davis 1998 Postmortem studies in schizophrenia Schizophr Bull 24 325 341
151. AC Puckett PK Pandya R Moucha W Dai MP Kilgard 2007 Plasticity in the rat posterior auditory field following nucleus basalis stimulation J Neurophysiol 98 253 265
152. TJ Raedler MB Knable DW Jones T Lafargue RA Urbina MF Egan D Pickar DR Weinberger 2000 In vivo olanzapine occupancy of muscarinic acetylcholine receptors in patients with schizophrenia Neuropsychopharmacology 23 56 68
153. TJ Raedler MB Knable DW Jones RA Urbina JG Gorey KS Lee MF Egan R Coppola DR Weinberger 2003 In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia Am J Psychiatry 160 118 127
154. TJ Raedler FP Bymaster R Tandon D Copolov B Dean 2007 Towards a muscarinic hypothesis of schizophrenia Mol Psychiatry 12 232 246
155. G Remington S Kapur 2005 Remission: what's in a name? Am J Psychiatry 162 2393 2394
156. JB Richards MJ Baggott KE Sabol LS Seiden 1993 A high-dose methamphetamine regimen results in long-lasting deficits on performance of a reaction-time task Brain Res 627 254 260
157. RM Ridley HF Baker F Owen AJ Cross TJ Crow 1982 Behavioural and biochemical effects of chronic amphetamine treatment in the vervet monkey Psychopharmacology 78 245 251
158. PH Robert V Migneco I Chaix L Berthet M Kazes JM Danion C Baudu G Darcourt 1997 Use of a sequencing task designed to stress the supervisory system in schizophrenic subjects Psychol Med 27 1287 1294
159. TE Robinson JB Becker 1986 Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis Brain Res 396 157 198
160. TE Robinson DM Camp 1987 Long-lasting effects of escalating doses of d-amphetamine on brain monoamines, amphetamine-induced stereotyped behavior and spontaneous nocturnal locomotion Pharmacol Biochem Behav 26 821 827
161. TE Robinson PA Jurson JA Bennett KM Bentgen 1988 Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats Brain Res 462 211 222
162. H Russig A Durrer BK Yee CA Murphy J Feldon 2003 The acquisition, retention and reversal of spatial learning in the morris water maze task following withdrawal from an escalating dosage schedule of amphetamine in wistar rats Neuroscience 119 167 179
163. M Sarter 1990 Retrieval of well-learned propositional rules: insensitive to changes in activity of individual neurotransmitter systems? Psychobiology 18 451 459
164. M Sarter JP Bruno 1999 Abnormal regulation of corticopetal cholinergic neurons and impaired information processing in neuropsychiatric disorders Trends Neurosci 22 67 74
165. M Sarter B Givens JP Bruno 2001 The cognitive neuroscience of sustained attention: where top-down meets bottom-up Brain Res Rev 35 146 160
166. M Sarter ME Hasselmo JP Bruno B Givens 2005 Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection Brain Res Rev 48 98 111
167. M Sarter CL Nelson JP Bruno 2005 Cortical cholinergic transmission and cortical information processing following psychostimulant-sensitization: implications for models of schizophrenia Schizophren Bull 31 117 138
168. M Sarter WJ Gehring R Kozak 2006 More attention must be paid: the neurobiology of attentional effort Brain Res Rev 51 145 160
169. M Sarter JP Bruno V Parikh 2007 Abnormal neurotransmitter release underlying behavioral and cognitive disorders: toward concepts of dynamic and function-specific dysregulation Neuropsychopharmacology 32 1452 1461
170. Scarr E, Cowie TF, Kanellakis S, Sundram S, Pantelis C, Dean B (2008) Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia. Mol Psychiatry, in press
171. DS Segal DS Janowski 1978
172. DS Segal R Kuczenski 1997 An escalating dose "binge" model of amphetamine psychosis: behavioral and neurochemical characteristics J Neurosci 17 2551 2566
173. DS Segal AJ Mandell 1974 Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy Pharmacol Biochem Behav 2 249 255
174. DS Segal MA Geyer MA Schuckit 1981
175. LJ Seidman KJ Van Manen WM Turner DM Gamser SV Faraone JM Goldstein MT Tsuang 1998 The effects of increasing resource demand on vigilance performance in adults with schizophrenia or developmental attentional/learning disorders: a preliminary study Schizophr Res 34 101 112
176. D Servan-Schreiber JD Cohen S Steingard 1996 Schizophrenic deficits in the processing of context. A test of a theoretical model Arch Gen Psychiatry 53 1105 1112
177. H Silver P Feldman 2005 Evidence for sustained attention and working memory in schizophrenia sharing a common mechanism J Neuropsychiatry Clin Neurosci 17 391 398
178. DM Small D Gitelman K Simmons SM Bloise T Parrish MM Mesulam 2005 Monetary incentives enhance processing in brain regions mediating top-down control of attention Cereb Cortex 15 1855 1865
179. GL Smith MM Large DJ Kavanagh F Karayanidis NA Barrett PT Michie BT O'Sullivan 1998 Further evidence for a deficit in switching attention in schizophrenia J Abnorm Psychol 107 390 398
180. SH Snyder 1973 Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines Am J Psychiatry 130 61 67
181. SH Snyder GK Aghajanian S Matthysse 1972 Prospects for research on schizophrenia. V. Pharmacological observations, drug-induced psychoses Neurosci Res Program Bull 10 430 445
182. SM Strakowski KW Sax MJ Setters SP Stanton PE Keck Jr 1997 Lack of enhanced response to repeated d-amphetamine challenge in first-episode psychosis: implications for a sensitization model of psychosis in humans Biol Psychiatry 42 749 755
183. ME Strauss 1993 Relations of symptoms to cognitive deficits in schizophrenia Schizophr Bull 19 215 231
184. CC Tenn PJ Fletcher S Kapur 2003 Amphetamine-sensitized animals show a sensorimotor gating and neurochemical abnormality similar to that of schizophrenia Schizophr Res 64 103 114
185. PH Venables 1964
186. M Wahba PT Donlon A Meadow 1981 Cognitive changes in acute schizophrenia with brief neuroleptic treatment Am J Psychiatry 138 1307 1310
187. TL Wallace GA Gudelsky CV Vorhees 2001 Neurotoxic regimen of methamphetamine produces evidence of behavioral sensitization in the rat Synapse 39 1 7
188. GG Wallis HJ Mc OC Scott 1949 Acute psychosis caused by dextro-amphetamine Br Med J 2 1394
189. M Watanabe 2007 Role of anticipated reward in cognitive behavioral control Curr Opin Neurobiol 17 213 219
190. GD Weese JM Phillips VJ Brown 1999 Attentional orienting is impaired by unilateral lesions of the thalamic reticular nucleus in the rat J Neurosci 19 10135 10139
191. IB Weiner 1964 Differential diagnosis in amphetamine psychosis Psychiatr Quart 38 707 716
192. DM Weiner HY Meltzer I Veinbergs EM Donohue TA Spalding TT Smith N Mohell SC Harvey J Lameh N Nash KE Vanover R Olsson K Jayathilake M Lee AI Levey U Hacksell ES Burstein RE Davis MR Brann 2004 The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine Psychopharmacology 177 207 216
193. DH Weissman GR Mangun MG Woldorff 2002 A role for top-down attentional orienting during interference between global and local aspects of hierarchical stimuli Neuroimage 17 1266 1276
194. DL Wolgin 2002 Effects of chronic amphetamine on the appetitive and consummatory phases of feeding Appetite 38 221 223
195. DL Wolgin JJ Jakubow 2004 Tolerance to amphetamine hypophagia: a real-time depiction of learning to suppress stereotyped movements in the rat Behav Neurosci 118 470 478
196. Young D, Martinez V, Bruno JP, Sarter M (2007) Neuronal mechanisms underlying the cognitive symptoms in a model of schizophrenia: prefrontal cholinergic inputs are necessary for attentional performance following repeated exposure to amphetamine. Soc Neurosci Abs #606.9
197. K Yui T Ishiguro K Goto S Ikemoto 1997 Precipitating factors in spontaneous recurrence of methamphetamine psychosis Psychopharmacology 134 303 308
198. K Yui K Goto S Ikemoto T Ishiguro B Angrist GE Duncan BB Sheitman JA Lieberman SH Bracha SF Ali 1999 Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitization Mol Psychiatry 4 512 523
199. K Yui K Goto S Ikemoto T Ishiguro 2000 Stress induced spontaneous recurrence of methamphetamine psychosis: the relation between stressful experiences and sensitivity to stress Drug Alcohol Depend 58 67 75
200. L Zaborszky RP Gaykema DJ Swanson WE Cullinan 1997 Cortical input to the basal forebrain Neuroscience 79 1051 1078
201. A Zmarowski M Sarter JP Bruno 2005 NMDA and dopamine interactions in the nucleus accumbens modulate cortical acetylcholine release Eur J Neurosci 22 1731 1740
202. A Zmarowski M Sarter JP Bruno 2007 Glutamate receptors in nucleus accumbens mediate regionally selective increases in cortical acetylcholine release Synapse 61 115 123